
Message to Pharma: Large Trials in Mesothelioma are Possible
by Lee Krug, MD, Memorial Sloan Kettering Cancer Center This month, a notification was sent to investigators on the DETERMINE Trial that accrual will be
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
by Lee Krug, MD, Memorial Sloan Kettering Cancer Center This month, a notification was sent to investigators on the DETERMINE Trial that accrual will be
***The Best of iMig 2014 updates were created by iMig and distributed to conference attendees during iMig 2014. The following is a verbatim re-post of
***The Best of iMig 2014 updates were created by iMig and distributed to conference attendees during iMig 2014. The following is a verbatim re-post of
***The Best of iMig 2014 updates were created by iMig and distributed to conference attendees during iMig 2014. The following is a verbatim re-post of
Dear supporter of mesothelioma research. We need your help! In March, Congresswoman Carolyn Maloney (D-NY) developed a formal letter requesting the U.S. House of Representatives
The Mesothelioma Applied Research Foundation congratulates Dr. Raffit Hassan of the National Cancer Institute (NCI) on receiving the prestigious Wagner Award at this year’s International
Mary Hesdorffer, NP, the executive director of the Meso Foundation is in attendance at the International Mesothelioma Interest Group (iMig) conference in Cape Town, South
Mary Hesdorffer, MS, APRN-BC, the executive director of the Meso Foundation, will be presenting at the 12th International Mesothelioma Interest Group (iMig) Conference in Cape